7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)

advanced adult primary liver cancer, carcinoma of the appendix, estrogen receptor-negative breast cancer, extensive stage small cell lung cancer, gastrointestinal stromal tumor, her2-negative breast cancer, metastatic gastrointestinal carcinoid tumor, ovarian sarcoma, ovarian stromal cancer, progesterone receptor-negative breast cancer, recurrent adenoid cystic carcinoma of the oral cavity, recurrent adult primary liver cancer